(Q47938852)

6 February 2018

review article

1 reference

title

Mechanisms of specific immunotherapy of allergic diseases (English)

1 reference

6 February 2018

1 reference

2

Jutel M

1 reference

6 February 2018

1

Kowalski ML

1 reference

6 February 2018

publication date

1 May 1998

1 reference

6 February 2018

published in

Allergy

1 reference

6 February 2018

volume

53

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

485-492

1 reference

6 February 2018

Specific immunotherapy in asthma: is it effective?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Combination of passive and active immunization in honeybee venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Combined active and passive immunotherapy in honeybee-sting allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

From epitopes to peptides to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Induction of antigen-specific suppressor cells in patients with hay fever receiving immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Functional subsets of allergen-reactive human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Regulation of interleukin-4 production in human mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

TH1 and TH2 CD4+ cells in human allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1998.TB04085.X

10.1111/J.1398-9995.1998.TB04085.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

release_orhzh7mekrbm5oeruocx6pni7i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/orhzh7mekrbm5oeruocx6pni7i

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9636807

1 reference

6 February 2018